The Carlyle Group Inc.
US ˙ NasdaqGS ˙ US14316J1088

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Anthony Welters. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Anthony Welters har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:GILD / Gilead Sciences, Inc. Director 11.748
US:CG / The Carlyle Group Inc. Director 56.305
US:L / Loews Corporation Director 9.845
US:BCR / C. R. Bard, Inc. - Corporate Bond/Note Director 0
US:WST / West Pharmaceutical Services, Inc. Director 62.142
US:UNH / UnitedHealth Group Incorporated EVP, UnitedHealth Group 119.909
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Anthony Welters. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CG / The Carlyle Group Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CG / The Carlyle Group Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2015-12-02 CG WELTERS ANTHONY 25.000 17,7714 25.000 17,7714 444.285 139 17.7000 -1.785 -0,40

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CG / The Carlyle Group Inc. Insider Trades
Insidersalg CG / The Carlyle Group Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CG / The Carlyle Group Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CG / The Carlyle Group Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Anthony Welters som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-08 2025-05-07 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 1.516 11.748 14,82
2025-05-02 2025-05-01 4 CG Carlyle Group Inc.
Common Stock
A - Award 5.235 56.305 10,25
2025-03-04 2025-03-03 4 L LOEWS CORP
Common Stock
S - Sale X -1.197 9.845 -10,84 86,87 -103.983 855.235
2025-03-04 2025-03-03 4 L LOEWS CORP
Common Stock
D - Sale to Issuer X -1.053 11.042 -8,71 86,89 -91.495 959.439
2025-03-04 2025-03-03 4 L LOEWS CORP
Common Stock
M - Exercise X 2.250 12.095 22,85 40,61 91.372 491.178
2024-12-03 2024-12-02 4 L LOEWS CORP
Common Stock
S - Sale X -1.146 9.845 -10,43 86,81 -99.484 854.644
2024-12-03 2024-12-02 4 L LOEWS CORP
Common Stock
D - Sale to Issuer X -1.104 10.991 -9,13 86,80 -95.827 954.019
2024-12-03 2024-12-02 4 L LOEWS CORP
Common Stock
M - Exercise X 2.250 12.095 22,85 42,52 95.670 514.279
2024-11-29 2024-11-27 4 CG Carlyle Group Inc.
Common Stock
G - Gift -13.280 51.070 -20,64
2024-09-04 2024-09-03 4 L LOEWS CORP
Common Stock
S - Sale X -1.088 9.845 -9,95 81,41 -88.574 801.481
2024-09-04 2024-09-03 4 L LOEWS CORP
Common Stock
D - Sale to Issuer X -1.162 10.933 -9,61 81,42 -94.610 890.165
2024-09-04 2024-09-03 4 L LOEWS CORP
Common Stock
M - Exercise X 2.250 12.095 22,85 41,98 94.455 507.748
2024-06-04 2024-06-03 4 L LOEWS CORP
Common Stock
S - Sale X -963 9.845 -8,91 75,80 -72.995 746.251
2024-06-04 2024-06-03 4 L LOEWS CORP
Common Stock
D - Sale to Issuer X -1.287 10.808 -10,64 76,59 -98.571 827.785
2024-06-04 2024-06-03 4 L LOEWS CORP
Common Stock
M - Exercise X 2.250 12.095 22,85 43,83 98.618 530.124
2024-05-09 2024-05-09 4 L LOEWS CORP
Common Stock
M - Exercise 1.706 9.845 20,96
2024-05-09 2024-05-08 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 2.310 10.232 29,16
2024-05-03 2024-05-01 4 CG Carlyle Group Inc.
Common Stock
A - Award 5.004 64.350 8,43
2024-03-04 2024-03-01 4 L LOEWS CORP
Common Stock
S - Sale X -951 8.139 -10,46 75,01 -71.335 610.506
2024-03-04 2024-03-01 4 L LOEWS CORP
Common Stock
D - Sale to Issuer X -1.299 9.090 -12,50 75,07 -97.516 682.386
2024-03-04 2024-03-01 4 L LOEWS CORP
Common Stock
M - Exercise X 2.250 10.389 27,64 43,37 97.582 450.571
2023-12-04 2023-12-01 4 L LOEWS CORP
Common Stock
S - Sale X -715 8.139 -8,08 70,16 -50.164 571.032
2023-12-04 2023-12-01 4 L LOEWS CORP
Common Stock
D - Sale to Issuer X -1.535 8.854 -14,78 70,08 -107.573 620.488
2023-12-04 2023-12-01 4 L LOEWS CORP
Common Stock
M - Exercise X 2.250 10.389 27,64 47,84 107.640 497.010
2023-05-10 2023-05-10 4 L LOEWS CORP
Common Stock
M - Exercise 1.567 8.139 23,84
2023-05-04 2023-05-03 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 1.887 7.922 31,27
2023-05-03 2023-05-01 4 CG Carlyle Group Inc.
Common Stock
A - Award 6.238 59.346 11,75
2022-12-22 2022-12-21 4 L LOEWS CORP
Common Stock
G - Gift -877 6.572 -11,77
2022-05-11 2022-05-11 4 L LOEWS CORP
Restricted Stock Units
M - Exercise -1.725 0 -100,00
2022-05-11 2022-05-11 4 L LOEWS CORP
Common Stock
M - Exercise 1.725 7.449 30,14
2022-05-11 2022-05-10 4 L LOEWS CORP
Restricted Stock Units
A - Award 1.567 1.567
2022-05-06 2022-05-05 4 GILD GILEAD SCIENCES, INC.
Non-qualified Stock Option (Right to Buy)
A - Award 15.851 15.851
2022-05-06 2022-05-05 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 2.444 6.035 68,06
2022-05-03 2022-05-03 4 GILD GILEAD SCIENCES, INC.
Restricted Stock Unit
M - Exercise -2.223 0 -100,00
2022-05-03 2022-05-03 4 GILD GILEAD SCIENCES, INC.
Common Stock
M - Exercise 2.223 3.591 162,50
2022-05-02 2022-05-01 4 CG Carlyle Group Inc.
Common Stock
A - Award 5.236 53.108 10,94
2022-01-04 2022-01-01 4 L LOEWS CORP
Restricted Stock Units
M - Exercise -1.959 0 -100,00
2022-01-04 2022-01-01 4 L LOEWS CORP
Common Stock
M - Exercise 1.959 5.724 52,03
2021-12-16 2021-12-14 4 L LOEWS CORP
Common Stock
G - Gift -1.755 3.765 -31,79
2021-12-13 2021-12-13 4 L LOEWS CORP
Common Stock
G - Gift -5.285 5.520 -48,91
2021-12-10 2021-12-08 4 CG Carlyle Group Inc.
Common Stock
G - Gift -10.951 47.872 -18,62
2021-10-26 2021-10-22 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
M - Exercise -1.368 2.223 -38,10
2021-10-26 2021-10-22 4 GILD GILEAD SCIENCES INC
Common Stock
M - Exercise 1.368 1.368
2021-09-03 2021-08-31 4 CG Carlyle Group Inc.
Common Stock
G - Gift -1.530 58.823 -2,54
2021-05-14 2021-05-12 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
A - Award 14.665 14.665
2021-05-14 2021-05-12 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
A - Award 2.223 3.591 162,50
2021-05-12 2021-05-12 4 L LOEWS CORP
Restricted Stock Units
M - Exercise -3.292 0 -100,00
2021-05-12 2021-05-12 4 L LOEWS CORP
Common Stock
M - Exercise 3.292 10.805 43,82
2021-05-12 2021-05-11 4 L LOEWS CORP
Restricted Stock Units
A - Award 1.725 1.725
2021-05-03 2021-05-01 4 CG Carlyle Group Inc.
Common Stock
A - Award 3.985 60.353 7,07
2020-10-26 2020-10-22 4 GILD GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy)
A - Award 7.718 7.718
2020-10-26 2020-10-22 4 GILD GILEAD SCIENCES INC
Restricted Stock Unit
A - Award 1.368 1.368
2020-05-14 2020-05-14 4 L LOEWS CORP
Restricted Stock Units
M - Exercise -1.979 0 -100,00
2020-05-14 2020-05-14 4 L LOEWS CORP
Common Stock
M - Exercise 1.979 7.513 35,76
2020-05-14 2020-05-12 4 L LOEWS CORP
Restricted Stock Units
A - Award 3.292 3.292
2020-05-05 2020-05-01 4 CG Carlyle Group Inc.
Common Stock
A - Award 5.411 56.368 10,62
2019-05-14 2019-05-14 4 L LOEWS CORP
Restricted Stock Units
A - Award 1.979 1.979
2019-05-03 2019-05-01 4 CG Carlyle Group L.P.
Common Units
A - Award 5.854 50.957 12,98
2018-12-13 2018-12-11 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 1.960 0,14
2018-12-13 2018-12-11 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.150 0,14
2018-09-13 2018-09-11 4 L LOEWS CORP
Restricted Stock Units
A - Award 2 1.957 0,12
2018-09-13 2018-09-11 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.147 0,13
2018-06-13 2018-06-12 4 L LOEWS CORP
Restricted Stock Units
A - Award 2 1.954 0,13
2018-06-13 2018-06-12 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.145 0,13
2018-05-09 2018-05-08 4 L LOEWS CORP
Restricted Stock Units
A - Award 1.952 1.952
2018-05-03 2018-05-01 4 CG Carlyle Group L.P.
Common Units
A - Award 5.826 45.103 14,83
2018-03-15 2018-03-13 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.142 0,12
2018-01-03 2017-12-29 4 BCR BARD C R INC /NJ/
Share Equivalent Units
D - Sale to Issuer -17.808 0 -100,00
2018-01-03 2017-12-29 4 BCR BARD C R INC /NJ/
Phantom Stock Units
D - Sale to Issuer -20.597 0 -100,00
2018-01-03 2017-12-29 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 83 20.597 0,41 331,24 27.632 6.822.517
2018-01-03 2017-12-29 4 BCR BARD C R INC /NJ/
Common Stock
D - Sale to Issuer -4.520 0 -100,00
2017-12-14 2017-12-12 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.139 0,13
2017-12-05 2017-12-04 4 BCR BARD C R INC /NJ/
Share Equivalent Units
A - Award 245 17.808 1,39
2017-12-05 2017-12-04 4 BCR BARD C R INC /NJ/
Common Stock
A - Award 298 4.520 7,06
2017-09-14 2017-09-12 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.137 0,13
2017-07-05 2017-07-03 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 169 20.481 0,83 316,39 53.502 6.479.863
2017-06-15 2017-06-13 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.134 0,13
2017-06-01 2017-05-30 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2017-06-01 2017-05-30 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2017-06-01 2017-05-30 4 BCR BARD C R INC /NJ/
Common Stock
F - Taxes -662 4.222 -13,55 309,24 -204.720 1.305.632
2017-06-01 2017-05-30 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 4.884 32,57 81,70 98.034 398.998
2017-06-01 2017-05-30 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 3.684 48,31 88,76 106.506 326.973
2017-05-26 2017-05-24 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2017-05-26 2017-05-24 4 BCR BARD C R INC /NJ/
Common Stock
F - Taxes -325 2.484 -11,57 308,35 -100.214 765.941
2017-05-26 2017-05-24 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 2.809 74,58 83,47 100.168 234.476
2017-05-11 2017-05-10 4 L LOEWS CORP
Restricted Stock Units
M - Exercise -2.534 0 -100,00
2017-05-11 2017-05-10 4 L LOEWS CORP
Common Stock
M - Exercise 2.534 5.534 84,47
2017-05-11 2017-05-09 4 L LOEWS CORP
Restricted Stock Units
A - Award 2.131 2.131
2017-05-03 2017-05-01 4 CG Carlyle Group L.P.
Common Units
A - Award 5.634 39.277 16,75
2017-03-15 2017-03-14 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.534 0,13
2017-01-05 2017-01-03 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 228 20.272 1,13 227,47 51.749 4.611.320
2017-01-05 2016-12-21 4 BCR BARD C R INC /NJ/
Common Stock
G - Gift -767 1.609 -32,28
2016-12-15 2016-12-14 4 BCR BARD C R INC /NJ/
Share Equivalent Units
A - Award 375 17.563 2,18
2016-12-15 2016-12-14 4 BCR BARD C R INC /NJ/
Common Stock
A - Award 468 2.376 24,53
2016-12-15 2016-12-13 4 L LOEWS CORP
Restricted Stock Units
A - Award 3 2.531 0,13
2016-09-14 2016-09-13 4 L LOEWS CORP
Restricted Stock Units
A - Award 4 2.528 0,15
2016-07-06 2016-07-01 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 213 19.998 1,08 234,75 50.100 4.694.427
2016-06-16 2016-06-14 4 L LOEWS CORP
Restricted Stock Units
A - Award 4 2.524 0,16
2016-05-11 2016-05-10 4 L LOEWS CORP
Restricted Stock Units
A - Award 2.520 2.520
2016-05-03 2016-05-01 4 CG Carlyle Group L.P.
Common Units
A - Award 5.974 33.643 21,59
2016-04-04 2016-03-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 290 62.142 0,47 68,91 20.000 4.282.227
2016-02-18 2016-02-16 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2016-02-18 2016-02-16 4 BCR BARD C R INC /NJ/
Common Stock
S - Sale -1.784 1.908 -48,32 187,47 -334.453 357.700
2016-02-18 2016-02-16 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 3.692 48,15 73,99 88.788 273.171
2016-01-08 2015-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 287 61.721 0,47 61,07 17.500 3.769.316
2016-01-06 2016-01-04 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 301 19.737 1,55 183,90 55.400 3.629.552
2016-01-05 2015-12-31 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2015-12-11 2015-12-09 4 BCR BARD C R INC /NJ/
Share Equivalent Units
A - Award 442 17.188 2,64
2015-12-11 2015-12-09 4 BCR BARD C R INC /NJ/
Common Stock
A - Award 536 2.492 27,40
2015-12-04 2015-12-02 4 L LOEWS CORP
Common Stock
P - Purchase 3.000 3.000 38,31 114.930 114.930
2015-12-03 2015-12-02 4 CG Carlyle Group L.P.
Common Units
P - Purchase 25.000 27.669 936,68 17,77 444.285 491.717
2015-11-03 2015-11-01 4 CG Carlyle Group L.P.
Common Units
A - Award 2.669 2.669
2015-10-05 2015-10-01 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 319 61.254 0,52 54,83 17.500 3.358.559
2015-10-02 2015-09-30 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2015-07-02 2015-07-01 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 263 19.387 1,38 172,77 45.501 3.349.423
2015-07-02 2015-06-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 301 60.886 0,50 58,13 17.500 3.539.281
2015-07-01 2015-06-30 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2015-05-07 2015-05-05 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.448 43.536 5,96
2015-04-02 2015-03-31 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2015-04-02 2015-03-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 293 60.327 0,49 59,66 17.500 3.599.131
2015-02-11 2015-02-09 4 BCR BARD C R INC /NJ/
Common Stock
S - Sale -1.563 1.956 -44,42 169,02 -264.177 330.602
2015-02-09 2014-12-31 4/A WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 325 60.034 0,54
2015-01-06 2015-01-02 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 282 19.074 1,50 167,48 47.151 3.194.542
2015-01-05 2014-12-31 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2015-01-05 2014-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 325 59.962 0,55
2014-12-12 2014-12-10 4 BCR BARD C R INC /NJ/
Share Equivalent Units
A - Award 413 16.746 2,53
2014-12-12 2014-12-10 4 BCR BARD C R INC /NJ/
Common Stock
A - Award 605 3.519 20,76
2014-10-02 2014-09-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 389 59.580 0,66
2014-10-02 2014-09-30 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2014-07-02 2014-07-01 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 312 18.740 1,69 145,82 45.500 2.732.649
2014-07-02 2014-06-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 416 59.045 0,71 42,02 17.500 2.481.079
2014-07-01 2014-06-30 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2014-05-08 2014-05-06 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 3.016 40.763 7,99
2014-04-02 2014-03-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 406 58.480 0,70
2014-04-01 2014-03-31 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2014-01-27 2013-12-31 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 357 57.959 0,62
2014-01-06 2014-01-02 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 370 18.371 2,06 131,83 48.800 2.421.883
2014-01-02 2013-12-31 4 L LOEWS CORP
Stock Appreciation Right
A - Award 2.250 2.250
2013-12-13 2013-12-11 4 BCR BARD C R INC /NJ/
Share Equivalent Units
A - Award 512 16.333 3,24
2013-12-13 2013-12-11 4 BCR BARD C R INC /NJ/
Common Stock
A - Award 767 2.914 35,72
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -3.200 0 -100,00 28,25 -90.400
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -6.400 0 -100,00 19,36 -123.936
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -6.400 0 -100,00 36,10 -231.040
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -3.200 0 -100,00 26,37 -84.384
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -19.200 18.762 -50,58 78,43 -1.505.875 1.471.551
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 3.200 37.962 9,21 26,37 84.384 1.001.068
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 3.200 34.762 10,14 28,25 90.400 982.037
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 6.400 31.562 25,43 19,36 123.936 611.205
2013-08-14 2013-08-12 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 6.400 25.162 34,11 36,10 231.040 908.362
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Common Stock
S - Sale -5.600 2.147 -72,29 113,12 -633.474 242.869
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 7.747 18,33 54,96 65.958 425.814
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 6.547 22,44 57,01 68.412 373.244
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 5.347 28,94 63,43 76.116 339.160
2013-07-30 2013-07-26 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 4.147 40,72 66,80 80.154 276.999
2013-07-02 2013-07-01 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 436 17.941 2,49 108,17 47.150 1.940.664
2013-05-09 2013-05-07 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.003 18.719 11,98
2013-02-08 2013-02-07 4 BCR BARD C R INC /NJ/
Common Stock
G - Gift -800 2.947 -21,35
2013-02-08 2013-02-06 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2013-02-08 2013-02-06 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2013-02-08 2013-02-06 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise -2.400 3.747 -39,04 101,48 -243.557 380.253
2013-02-08 2013-02-06 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 6.147 24,26 35,71 42.852 219.509
2013-02-08 2013-02-06 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 4.947 32,03 39,36 47.235 194.726
2013-01-04 2013-01-02 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 395 17.436 2,32 101,83 40.200 1.775.557
2012-12-14 2012-12-12 4 BCR BARD C R INC /NJ/
Share Equivalent Units
A - Award 715 15.821 4,73
2012-12-14 2012-12-12 4 BCR BARD C R INC /NJ/
Common Stock
A - Award 584 3.747 18,46
2012-12-14 2012-08-07 4 BCR BARD C R INC /NJ/
Common Stock
G - Gift -1.600 3.163 -33,59
2012-10-02 2012-09-28 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 236 28.394 0,84
2012-08-14 2012-08-07 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -600 16.568 -3,49
2012-07-03 2012-07-02 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 437 16.971 2,64 107,83 47.150 1.830.034
2012-07-03 2012-06-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 229 28.055 0,82
2012-06-07 2012-06-05 4 UNH UNITEDHEALTH GROUP INC
Common Stock
F - Taxes -7.211 119.909 -5,67 56,04 -404.104 6.719.691
2012-05-03 2012-05-01 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.459 17.120 16,77
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Stock Appreciation Right
M - Exercise -38.012 38.012 -50,00
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Stock Appreciation Right
M - Exercise -28.280 28.280 -50,00
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Stock Appreciation Right
M - Exercise -23.639 21.212 -52,71
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Non-Qualified Stock Option (right to buy)
M - Exercise -70.000 200.000 -25,93
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Common Stock
S - Sale -90.571 127.120 -41,61 59,07 -5.349.775 7.508.613
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Common Stock
F - Taxes -28.225 217.691 -11,48 59,51 -1.679.670 12.954.782
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Common Stock
M - Exercise 38.012 245.916 18,28 33,00 1.254.396 8.115.223
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Common Stock
F - Taxes -20.103 207.904 -8,82 59,51 -1.196.330 12.372.357
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Common Stock
M - Exercise 28.280 228.007 14,16 29,74 841.047 6.780.923
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Common Stock
F - Taxes -17.769 199.727 -8,17 59,51 -1.057.433 11.885.744
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Common Stock
M - Exercise 23.639 217.496 12,19 33,94 802.308 7.381.809
2012-04-24 2012-04-23 4 UNH UNITEDHEALTH GROUP INC
Common Stock
M - Exercise 70.000 193.857 56,52 42,86 3.000.550 8.309.673
2012-04-02 2012-03-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 316 27.714 1,15
2012-03-20 2012-03-19 4 UNH UNITEDHEALTH GROUP INC
Common Stock
A - Award 216 123.857 0,17
2012-03-09 2012-03-08 4 UNH UNITEDHEALTH GROUP INC
Common Stock
S - Sale -30.000 123.641 -19,53 55,54 -1.666.266 6.867.294
2012-02-24 2012-02-23 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -9.000 0 -100,00 13,99 -125.932
2012-02-24 2012-02-23 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -9.000 14.610 -38,12 42,61 -383.531 622.611
2012-02-24 2012-02-23 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 9.000 23.610 61,60 13,99 125.932 330.367
2012-02-14 2012-02-13 4 UNH UNITEDHEALTH GROUP INC
Common Stock
S - Sale -76.000 153.641 -33,10 53,58 -4.071.753 8.231.425
2012-02-10 2012-02-09 4 UNH UNITEDHEALTH GROUP INC
Common Stock
F - Taxes -3.088 229.641 -1,33 53,06 -163.849 12.184.752
2012-02-10 2012-02-09 4 UNH UNITEDHEALTH GROUP INC
Common Stock
F - Taxes -5.862 232.729 -2,46 53,06 -311.038 12.348.601
2012-02-09 2012-02-07 4 UNH UNITEDHEALTH GROUP INC
Common Stock
F - Taxes -64.924 238.591 -21,39 52,03 -3.377.996 12.413.890
2012-02-09 2012-02-07 4 UNH UNITEDHEALTH GROUP INC
Common Stock
A - Award 153.846 303.515 102,79
2012-02-09 2012-02-07 4 UNH UNITEDHEALTH GROUP INC
Common Stock
A - Award 38.440 149.669 34,56 52,03 2.000.033 7.787.279
2012-02-07 2012-02-03 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -2.400 0 -100,00
2012-02-07 2012-02-03 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2012-02-07 2012-02-03 4 BCR BARD C R INC /NJ/
Option (Right to Buy)
M - Exercise -1.200 0 -100,00
2012-02-07 2012-02-03 4 BCR BARD C R INC /NJ/
Common Stock
S - Sale -4.800 4.763 -50,19 93,23 -447.493 444.044
2012-02-07 2012-02-03 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 9.563 14,35 26,01 31.215 248.758
2012-02-07 2012-02-03 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 1.200 8.363 16,75 28,04 33.645 234.478
2012-02-07 2012-02-03 4 BCR BARD C R INC /NJ/
Common Stock
M - Exercise 2.400 7.163 50,39 25,71 61.704 184.161
2012-02-07 2012-02-03 4 UNH UNITEDHEALTH GROUP INC
Common Stock
F - Taxes -2.957 111.229 -2,59 51,31 -151.724 5.707.161
2012-01-04 2012-01-03 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 289 16.470 1,79 86,37 25.000 1.422.491
2012-01-04 2011-12-31 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 201 16.180 1,26 85,50 17.200 1.383.415
2012-01-03 2011-12-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit
A - Award 435 27.278 1,62 37,93 16.500 1.034.666
2010-07-06 2010-07-01 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 164 14.678 1,13 76,29 12.500 1.119.769
2010-07-01 2010-06-30 4 BCR BARD C R INC /NJ/
Phantom Stock Units
A - Award 137 14.514 0,95 77,53 10.600 1.125.267
2007-09-21 3 UNH UNITEDHEALTH GROUP INC
Common Stock
3.453
2004-07-15 2004-07-14 4 bcr BARD C R INC /NJ/
Option (Right to Buy)
A - Award 600 600
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)